Is protease inhibitors based antiretroviral therapy during pregnancy associated with an increased risk of preterm birth? Systematic review and a meta-analysis
- PMID: 27048501
- PMCID: PMC4822312
- DOI: 10.1186/s12978-016-0149-5
Is protease inhibitors based antiretroviral therapy during pregnancy associated with an increased risk of preterm birth? Systematic review and a meta-analysis
Abstract
Background: Antiretroviral therapy is recommended during pregnancy to decrease the risk of perinatal transmission of HIV-1 infection and to improve maternal health. However, some studies have reported that antiretroviral treatment (ART) containing protease inhibitors (PI) is associated with an increased risk of preterm birth. In contrast, other studies have reported no increased risk. This meta-analysis was conducted to derive a more reliable estimate of the association between the prenatal use of PI based ART regimen and preterm birth.
Methods: A systemic review and meta-analysis was conducted using published studies which were identified through a computerized search using the Medline/PubMed database, Google Scholar and Health Inter Network Access to Research Initiative (HINARI). The analysis was undertaken using STATA version 11.0 software and studies were described by forest plot. Heterogeneity across studies was checked using Cochran Q test and I2 test. An adjusted odd ratio with 95% confidence intervals [95% CI] was pooled using a random effects model.
Results: The Cochrane Q test (Q test p = 0.051) showed a good homogeneity among studies. However, medium heterogeneity was observed in up to 46% of the sample using the I2 test (I2 = 46.5%). The Egger weighted regression method (p = 0.04) showed evidence of publication bias, but Begg rank correlation statistics (p = 0.47) did not show evidence of publication bias. The pooled analysis of 10 studies showed that protease based ART exposure during pregnancy was associated with an increased risk of preterm birth (pooled odds ratio 1.32 (95% CI, 1.04 to 1.59).
Conclusions: This meta-analysis revealed that the PI based ART exposure during pregnancy is significantly associated with an increased risk of preterm birth. There should be strong cautions against initiating ART during pregnancy and PI based ARV should be replaced by others drug regime. Protease inhibitor ART drugs should not be included as part of therapy during pregnancy.
Keywords: Antiretroviral therapy; HIV; Pregnancy; Prematurity; Preterm birth; Protease inhibitors; Risk factors.
Figures
![Fig. 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4822312/bin/12978_2016_149_Fig1_HTML.gif)
![Fig. 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4822312/bin/12978_2016_149_Fig2_HTML.gif)
![Fig. 3](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4822312/bin/12978_2016_149_Fig3_HTML.gif)
![Fig. 4](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4822312/bin/12978_2016_149_Fig4_HTML.gif)
![Fig. 5](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4822312/bin/12978_2016_149_Fig5_HTML.gif)
Similar articles
-
Association between maternal human immunodeficiency virus infection and preterm birth: A matched case-control study from a pregnancy outcome registry.Medicine (Baltimore). 2021 Jan 29;100(4):e22670. doi: 10.1097/MD.0000000000022670. Medicine (Baltimore). 2021. PMID: 33530154 Free PMC article.
-
Premature delivery in HIV-infected women starting protease inhibitor therapy during pregnancy: role of the ritonavir boost?Clin Infect Dis. 2012 May;54(9):1348-60. doi: 10.1093/cid/cis198. Epub 2012 Mar 28. Clin Infect Dis. 2012. PMID: 22460969
-
Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.Cochrane Database Syst Rev. 2010 Mar 17;(3):CD008440. doi: 10.1002/14651858.CD008440. Cochrane Database Syst Rev. 2010. PMID: 20238370 Review.
-
Prenatal protease inhibitor use and risk of preterm birth among HIV-infected women initiating antiretroviral drugs during pregnancy.J Infect Dis. 2010 Apr 1;201(7):1035-44. doi: 10.1086/651232. J Infect Dis. 2010. PMID: 20196654 Free PMC article.
-
Use of antiretroviral therapy in pregnant HIV-infected women and the risk of premature delivery: a meta-analysis.AIDS. 2007 Mar 12;21(5):607-15. doi: 10.1097/QAD.0b013e32802ef2f6. AIDS. 2007. PMID: 17314523 Review.
Cited by
-
Comparative risk of adverse perinatal outcomes associated with classes of antiretroviral therapy in pregnant women living with HIV: systematic review and meta-analysis.Front Med (Lausanne). 2024 Feb 27;11:1323813. doi: 10.3389/fmed.2024.1323813. eCollection 2024. Front Med (Lausanne). 2024. PMID: 38476445 Free PMC article.
-
Antiretroviral Therapy in Pregnancy: A 2023 Review of the Literature.Curr HIV/AIDS Rep. 2024 Feb;21(1):1-10. doi: 10.1007/s11904-024-00688-y. Epub 2024 Jan 26. Curr HIV/AIDS Rep. 2024. PMID: 38277098 Free PMC article. Review.
-
Circulating levels of inflammatory mediators in pregnant people living with HIV according to antiretroviral therapy regimen.Front Microbiol. 2024 Jan 8;14:1282291. doi: 10.3389/fmicb.2023.1282291. eCollection 2023. Front Microbiol. 2024. PMID: 38260915 Free PMC article.
-
Congenital malformations and preeclampsia associated with integrase inhibitor use in pregnancy: A single-center analysis.PLoS One. 2023 Jun 12;18(6):e0276473. doi: 10.1371/journal.pone.0276473. eCollection 2023. PLoS One. 2023. PMID: 37307279 Free PMC article.
-
Adverse pregnancy outcomes associated with antiretroviral therapy initiated before pregnancy and during pregnancy: a retrospective study in Hubei province, China.Front Med (Lausanne). 2023 May 18;10:1158962. doi: 10.3389/fmed.2023.1158962. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37275371 Free PMC article.
References
-
- World Health Organization. Antiretroviral drugs for treating pregnant women and preventing HIV infections in infants: recommendations for a public health approach 2010 version. http://whqlibdoc.who.int/publications/2010. - PubMed
-
- Copper ER, Charurat M, Mofenson L, Hanson IC, Pitt J, Diaz C, et al. Combination antiretroviral strategies for the treatment of pregnant HIV-1 infected women and prevention of prenatal HIV-1 transition. J Aquir Immune Defic Syndr. 2002;29(5):484–494. doi: 10.1097/00042560-200204150-00009. - DOI - PubMed
-
- Senise JF, Castelo A, Martinez M. Current treatment strategies, complications and considerations for the use of HIV antiretroviral therapy during pregnancy. AIDS Rev. 2011;13:198–213. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous